There appears to be very good epidemiological evidence for a relationship between chlorination by-products, as measured by trihalomethanes (THMs), in drinking water and bladder cancer, but the evidence for other cancers, including colorectal cancer appears to be inconclusive and inconsistent. There appears to be some evidence for a relationship between chlorination by-products, as measured by THMs, and small for gestational age (SGA)/intrauterine growth retardation (IUGR) and preterm delivery, but evidence for other outcomes such as low birth weight (LBW), stillbirth, congenital anomalies and semen quality appears to be inconclusive and inconsistent.
INTRODUCTION
It has been more than 30 years since trihalomethanes (THMs) were first discovered in the Netherlands (Rooks 1974) . Chlorination disinfection by-products (DBPs) are formed when water is chlorinated and the organic matter in the water reacts with chlorine to form these by-products.
The formation and occurrence depends on many factors, including the chlorine dose, type of treatment, pH, temperature, residence time and bromine levels (Nieuwenhuijsen et al. 2000a; IPCS 2000) . Up to 600 DBPs have been identified (Richardson 1998; Richardson et al. 2008) .
Different mixtures of by-product may exist in different locations depending on the various factors mentioned above, making it more difficult to assess any health effects of DBPs, particularly in epidemiological studies. In Europe there is relatively little known about the occurrence of DBPs other than THMs and their levels (Palacios et al. 2000) , with some exceptions in a few places such as Poland (Dojlido et al. 1999) , Finland (Nissinen et al. 2002) , Spain (Villanueva et al. 2003) , the UK (Malliarou et al. 2005) , Greece (Golfinopoulos & Nikolaou 2005) and Italy (Fantuzzi et al. 2007) , while in the US extensive surveys have been conducted to assess DBP occurrence under different water treatment methods (e.g. Weinberg et al. 2002; Krasner et al. 2006 ).
In the USA and Canada there has been considerable progress in the assessment of health risks and policy development in relation to DBPs, including a research programme on the occurrence and health risks relation to the by-products by the USEPA's office on Water and National
Health and Environmental Effects Research Laboratory
(http://www.epa.gov/nheerl/research/drinking_water.html).
A considerable amount of work has been carried out measuring a range of different DBPs, animal testing of a list of high priority by-products and epidemiological studies.
However, results may not be extended to Europe because mixtures of DBPs may be different as a result of different determinants such as treatment, total organic content (TOC), pH etc. In Europe there has been a much slower response to the recent findings. Disinfection is used in many countries in Europe and is therefore of European concern and requests a European approach and solution. Relatively little research has been carried out on DBPs in relation to adverse birth outcomes and cancer in Europe. Where work has been carried out, this has been carried out in isolation.
Safe drinking water has a high priority in Europe in accordance with the Water Framework Directive and the Directive on Quality of Water intended for Human Consumption. Water treatment safety has become particularly acute since the quality of water resources may be declining because of water scarcity in some regions, increasing the cost of drinking water production and the likelihood of chemical interactions during the treatment process. Water is an important part of the food chain.
Consumer health and well-being, quality, safety and consumer concern, are highly important and should be addressed where possible, particularly where environmental health risks are concerned. Recently there has been consumer concern about the quality of drinking water from the tap and this may have led to an increase in the consumption of expensive bottled water in developed nations (Doria et al. 2005; Doria 2006) , reducing the money that can be spent on more beneficial items.
Ingestion of water may not be the only concern since an individual can also be exposed to volatile DBPs (e.g. THMs) through inhalation and absorption, during activities such as showering, bathing and swimming (Nieuwenhuijsen et al. 2000a) . Recent modelling has suggested that this route may lead to the highest levels in the blood (Whitaker et al. 2003) .
Uptake through showering, bathing and swimming showed considerable increased risk in a recent bladder cancer study . For non-volatile DBPs, such as haloacetic acids (HAAs), ingestion is thought to be the main route of exposure.
In this paper we briefly summarise the epidemiological evidence and limitations regarding the two main areas of health effects from exposure to DBPs, cancer and reproductive effects. We then present the background and design of a major research initiative in the EU (Health Impacts of long-term exposure to disinfection by-products in drinking WATEr, HIWATE project) that will provide an extensive evaluation of exposure, hazard identification, risk assessment and risk benefit analysis for these compounds in the EU.
EPIDEMIOLOGICAL STUDIES EXAMINING HEALTH EFFECTS RELATED TO EXPOSURE TO DISINFECTION BY-PRODUCTS Cancer
The health effects of DBPs in drinking water have been a concern since DBPs were first reported in the 1970s. Early studies focused on cancer outcomes, while the more recent studies have focused on reproductive outcomes (IPCS 2000) . According to the recent review by IPCS (2000): The document also mentioned the difficulties in exposure assessment for epidemiological studies of cancer and DBPs, due to the long lag periods and the general lack of detailed historical data.
A very important recent pooled analysis by Villanueva et al. (2004) , which provided quantitative information, confirmed this. For men there was an exposure response relationship between DBP intake and bladder cancer, but there was no relationship in women (Table 1) . Furthermore, the latest Spanish study suggested that not only is exposure through ingestion an important risk factor but also exposure through swimming, showering and bathing ). Furthermore in this study the authors identified genetically susceptible groups such as those with glutathione S-transferase theta 1 (GSTT1) and glutathione S-transferase zeta 1 (GSTZ1) polymorphisms . Some studies have suggested an association between DBPs and colorectal cancers, while others have not (Young et al. 1981 (Young et al. , 1987 Wilkins & Comstock 1981; Doyle et al. 1997; Koivusalo & Vartiainen 1997; Hildesheim et al. 1998; King et al. 2000a; Bove et al. 2007) . Studies on colorectal cancer have relatively limited sample size and have used relatively crude measures of exposure assessment focusing principally on THMs levels in the water, without examining different exposures or gene -environment interactions. There is little evidence for an association between exposure to DBPs and other cancers such as liver, kidney, brain, lung and breast cancer, lymphomas or cancer of the pancreas, but the number of studies is small (IPCS 2000) and very few of these have involved populations in Europe. A recent report suggested an association between THMs and skin cancer, but further work needed to be conducted (Karagas et al. 2008) .
Reproductive outcomes
Reproductive health outcomes should be easier to study from an exposure point of view, because of the shorter relevant exposure period. Among others, birth weight, prematurity, spontaneous abortion, congenital anomalies and stillbirth have been the focus of these studies. Overall there appears to be some evidence for a relationship between chlorination by-products, as measured by THMs, and small for gestational age (SGA)/intrauterine growth retardation (IUGR) and preterm delivery, but evidence for other outcomes such as low birth weight (LBW), stillbirth, congenital anomalies and semen quality appears to be inconclusive and inconsistent (Kramer et al. 1992; Aschengrau et al. 1993; Bove et al. 1995 Bove et al. , 2002 Savitz et al. 1995 Savitz et al. , 2006 Kanitz et al. 1996; Reif et al. 1996; Gallagher et al. 1998; Waller et al. 1998 Waller et al. , 2001 Dodds et al. 1999 Dodds et al. , 2004  Klotz & Pyrch 1999; Magnus et al. 1999; King et al. 2000b King et al. , 2005 Kallen & Robert 2000; Yang et al. 2000 Yang et al. , 2007 Nieuwenhuijsen et al. 2000b Nieuwenhuijsen et al. , 2008 IPCS 2000; Gevecker Graves et al. 2001; Jaakkola et al. 2001; Dodds & King 2001; Cedergren et al. 2002; Hwang et al. 2002; Fenster et al. 2003; Hwang & Jaakkola 2003; Shaw et al. 2003; Wright et al. 2003 Wright et al. , 2004 Aggazzotti et al. 2004; Yang 2004; Hinckley et al. 2005; Porter et al. 2005; Toledano et al. 2005; Lewis et al. 2006 Lewis et al. , 2007 Tardiff et al. 2006; Luben et al. 2007 ). (Tomasi et al. 1985; Larson & Bull 1992; Ni et al. 1996; Scholl & Stein 2001; Meek et al. 2002; Gemma et al. 2003; Sciuto et al. 2003; Weber et al. 2003; Myatt & Cui 2004; Crider et al. 2005; Engel et al. 2005a,b; Min et al. 2006) , disruption of folate metabolism (Kamen 1997; Ray & Laskin 1999; Dow & Green 2000; Geter et al. 2005) , disruption of the synthesis and/or secretion of placental syncytiotrophoblast-derived chorionic gonadotropin (Chen et al. 2003 (Chen et al. , 2004 ) and lowering of testosterone levels (Potter et al. 1996) .
Limitations
The major limiting factor in these studies has generally been crude exposure assessment. Use of ecologic water supply zone estimates as an exposure index may result in exposure misclassification. Furthermore, ingestion has generally been the primary interest, while uptake through showering, bathing and swimming is considerable (Whitaker et al. 2003 Congenital malformations have often been classed into main categories (e.g. neural tube, major heart and abdominal defects) as a result of the small number of cases in the studies. These malformations, however, are generally heterogeneous with respect to both phenotype and presumed aetiology. Nieuwenhuijsen et al. (2008) showed that focusing on isolated subcategories may result in different findings.
Even though there has been some good animal work that suggests strong effects on semen quality (Smith et al. 1989; Toth et al. 1992; Linder et al. 1994a Linder et al. ,b, 1995 Linder et al. , 1997a , only two small US epidemiological studies have been conducted (Fenster et al. 2003; Luben et al. 2007 ). Table 2 ). The work is divided into different topics (exposure assessment, epidemiology, risk assessment and management) and studies (Table 3 ).
The specific objectives of the proposed work are outlined below.
Exposure assessment (I) To determine the DBP composition and levels in drinking water in various regions in Europe (see Table 4 ).
Representative water samples will be primarily collected in the regions where the epidemiological studies are carried out, to give a wider picture on their presence and levels.
Samples will be analysed for THMs (chloroform, bromodichloromethane, chlorodibromomethane and bromoform), In addition to the DBP analysis for a range of DBPs (see objective 1), the study will obtain information regarding the possible determinants of the DBPs including organic matter content, water source, temperature, pH and (residual) disinfectant levels (e.g. chlorine and bromide level) (Table 5) .
Statistical techniques will be employed to quantify the effect of these determinants on the formation of DBPs and use this to build a predictive model of DBP formation (Golfinopoulos & Arhonditsis 2002; Nikolaou et al. 2004; Whitaker et al. 2005) . Furthermore, the correlation between THMs and other DBPs will be assessed.
Initially a separate hierarchical model will be built to describe the data originating from each of the regions/countries. These region-specific models will be of a similar structure but the determinants included in the final models of each region may differ. We will explore ways in which these region-specific models might be combined, for instance by including an extra level in the hierarchy of the model structure. This extra level will allow us to explore the variability between the regions.
Basic mixture model
For each DBP and each region we will build a separate hierarchical model in order to describe the temporal and Furthermore, measurements under the detection limit will be modelled to obtain an estimate between 0 and the detection limit, rather than arbitrarily assigning a value of, for example, half the detection limit. In this approach a zone mean depends on measurements taken within that particular zone and the DBP levels for water of the same source type in other zones, taking into account seasonal variability across the region. This model can then be used, after it is back-transformed onto the original scale, to predict quarterly zone specific estimates of the DBP of interest. The model produces robust estimates for each zone together with an estimate of the degree of uncertainty around the estimates.
One of the main advantages of the model is that it provides good estimates for zones where few or no measurements are available. This hierarchical modelling approach fits well into a Bayesian framework and the software WinBUGS (Bayesian analysis using Gibbs sampling) will be used for the estimation (Spiegelhalter 2003) . These techniques have already been successfully applied elsewhere and provide a cost efficient way to provide exposure estimates for current and past exposures for epidemiological and risk assessment studies in areas where information on potential determinants is available, but where there is no or little information on DBP levels. In order to visualise the modelled DBP estimates and check for any unusual estimates or potential errors in the modelling, the modelled quarterly zone mean DBP estimates will be classified into exposure categories. The categorised DBP estimate for each zone and quarter will then be mapped for each water region, together with the raw annual mean DBP.
These will then be sent to the local water utilities for checking.
Regression modelling
The basic model described above aims to explain geo- By adding additional regression terms to the model described above we will seek to further explain the variability in the relevant modelled DBP. In determining the form of these regression models we will follow the regression mapping methodology used in this type of study (Sadiq & Rodriguez 2004) . Here, the fitted DBP levels at each sampling point, as produced in the above hierarchical model, are treated as fixed and become the dependent variable in a regression analysis against possible DBP formation determinants.
A simple statistical regression model can be expressed in the form:
where ln(C ij ) denotes the log transformed exposure con- Further, levels can be added to take account of multilevel effects.
Epidemiology
(III) To assess the risk of reproductive effects in relation to disinfection practices and levels of disinfection by-products, epidemiological studies will be conducted to examine the relationship between DBP exposure estimates and a number of outcomes.
(a) Congenital anomalies, including neural tube, major heart, major stomach wall, and urinary tract defects, cleft palate/lip will be studied in a large, nation-wide, crosssectional study, using registry data in the UK, where mainly chlorination is used as a disinfectant. Congenital anomalies, including neural tube, major heart and urinary tract defects will also be studied using registry data in Italy in the Emilia Romagna region, where mainly chlorine dioxide is used as a disinfectant. The study includes around 150,000 births and will be analysed as a Primary analysis will aim to determine whether there is evidence for a reduction in the rates of stillbirth after introduction of the new water treatment practices compared with before the changes took place. Secondary analysis will focus on specific THM species. Differences in small-area rates of stillbirth before and after treatment changes will be modelled against change in total and individual mean annual THM concentrations using Poisson regression. For each mg l 21 decrease in THM concentration, the increase/decrease in rates will be determined. In addition, areas will be categorised into low, medium and high change in THM concentrations and the change in rates of stillbirth will be estimated in each category using Poisson regression. Models will be adjusted for potential confounders such as maternal age and social deprivation (Carstairs' deprivation score and/or index of multiple deprivation).
(d) SGA, FGR and premature birth will be studied in five pregnancy cohorts in the UK, Spain, Greece, France and Lithuania (Table 6) , where a range of treatments are used. by-products, tap water samples will be taken from the study areas to measure trihalomethanes. They will also collect available data from water companies and local authorities.
The study population are administered a questionnaire including data on water consumption and water-related habits (e.g. showering, bathing, swimming pool use).
Cohort in Greece (Rhea study). The Greek birth cohort was initiated on the island of Crete and will enrol all births in one year within the prefecture of Heraklion, which includes urban and rural areas with different water supply sources (N ¼ 1,700). About one-third of the subjects live in rural or semi-urban areas and about one-fifth of the pregnant mother are recent immigrants. The existence of a well-developed health care system in Crete provides an Pooled analyses. We expect to be able to extract from the existing cohort studies (France, Spain) and obtain from the new cohort studies (Lithuania, Greece, UK) around 23,000
births for pooled analysis (Table 6 ). All subjects will have complete questionnaire data and in most cases both cord blood and mother's blood will be available. Exposure categories will be formed (e.g. none, low, medium and high) for initial analysis, followed by continuous indices, if appropriate. The cohorts in Crete, Bradford and Kaunas will measure many DBPs (through WP1) during the subjects' pregnancy, while INMA and PELAGIE have measurements on THMs and will collect information on many DBPs (through WP1) after the subjects' pregnancy.
Modelling techniques will be used (through WP2) to obtain estimates on various DBPs for all the subjects during the whole length of pregnancy.
Various exposure indices will be used including average exposure over the whole pregnancy and also average exposure during the first, second and third trimesters. Use of trimester-specific exposure estimates will allow evaluation of the critical exposure window. The questionnaires of all cohorts include information on the main confounders of interest such as maternal age and education, socioeconomic status, parity, smoking and alcohol consumption.
The outcomes that will be measured are: † low birth weight (LBW) † small for gestational age (SGA) including symmetrical and asymmetrical SGA † preterm delivery † foetal growth restriction (FGR) ! preferential measure † parameters derived from the ultrasounds etc.). The final selection of genes and SNPs to be analysed will be decided at a later stage. The genes to be analysed will include CYPE1, GSTT1, GSTZ and others.
(e) Semen quality will be studied using an existing casecontrol study (CHAPS-UK) (Clyma et al. 2008) in the UK, where mainly chlorination is used for water disinfection.
Subjects were drawn from new patients attending fertility clinics for investigation: sperm donors were specifically excluded. Cases were new male patients seen at any of the clinics over a 25 month period who had ,12 £ 10 6 ml 21 progressively motile sperm in their initial semen sample.
Around 1,700 cases and controls have been recruited. The study uses novel Bayesian statistics for the exposure assessment modelling ) and the exposure and health data will be linked in GIS (geographic information system). Information on potential confounders has been collected and the analyses of semen quality and DBP levels will be adjusted for potential confounders in logistic regression models. Unfortunately no information is available on the various exposure pathways and routes and only DBP concentrations in the water will be used as an exposure index for the critical exposure windows.
(IV) To assess the risk of cancer, particularly bladder cancer and colon cancer, in relation to disinfection byproduct practices and DBP levels, including the examination of any gene-environment interactions (e.g. CYP2E1, GSTT1).
The study will obtain risk estimates from existing casecontrol bladder cancer studies in Spain, France (includes ozonation as treatment) and Finland, and produce specific risk estimates for Europe. The work will build on a pooled analysis that has been conducted examining long-term exposure to chlorination by-products by combining residential information from questionnaires with information from water utilities gathered in six case-control studies from the US, Canada and Europe (Villanueva et al. 2004) . and large deletions (e.g. null GST alleles). The selected study design is the 'candidate gene approach' based on the analysis of those genes potentially involved in a functional way; for the first phase of the study we will focus on those involved in the DBP metabolism (e.g. GSTT1, CYP2E1, GSTZ1) and in folate metabolism (e.g. MFTHR). A comprehensive review will be conducted to identify key genes that may be involved in the interplay between DBP exposure and colorectal cancer risk. Candidate genes will be selected after discussion between partners. We will develop an overall framework for the risk - chlorination, chlorine dioxide and ozonation), and produce burden of disease estimates. The risk -benefit analyses will be the result of integrated DPBs and microbial risk assessments, from modelling of alternative treatment options and from different risk -benefit metrics, including burden of disease (e.g. DALYs). As far as we are aware only one such study has been reported in the literature, describing a risk -benefit model for Cryptosporidium parvum and bromate exposure and comparing the risks and benefits of ozonation using disability-adjusted life years (Havelaar et al. 2000) .
The work will start with a review to identify the relevant microbial and DBP exposures and related diseases (e.g.
infectious diarrhoea, gastrointestinal illness and reproductive and cancer outcomes, respectively). This will be followed by an exact framing of the risk assessment (more We will take into account the relationship with the raw water quality and its potential content and variability of microbial load (see e.g. Westrell et al. 2004) . Dose -response relationships will come from MICRORISK and the literature.
The dose-response of and the barrier efficiency of other treatment steps for several other specific microbes causing waterborne diseases worldwide but not routinely measured (including Campylobacteraceae, Mycobacteria, Giardia, Cryptosporidium, protozoa and enteric viruses)
for disinfection methods will be assessed (see e.g. Persson et al. 2005) . Also, the indicator value of heterotrophic plate counts for pathogenic waterborne bacteria will be evaluated.
Risk estimates for related infectious diseases will come from the EC-funded MICRORISK, other sources or will be derived where not available. For the risk assessment, a combined or best dose-response will be selected based on the ability to predict cases in an independent data set (validation with one of the studies, see above). Before entering the risk-benefit (or risk-risk) analysis, areas of non-independence of the microbiological and chemical risks will be examined (e.g. same susceptible or highly exposed populations, correlation between high DBPs exposure and higher microbial load). In all the above work, variability and uncertainty will be incorporated in the models and sensitivity analyses will be conducted on the results.
As part of the study, the water consumption, water treatment techniques, treatment performance in water works and raw water quality will be evaluated in the case study 
